501
Views
3
CrossRef citations to date
0
Altmetric
Letter to the Editor

Bendamustine in relapsed/refractory multiple myeloma: the “real-life” side of the moon

, , , , , , , , , , , , , , , , , , & show all
Pages 1510-1513 | Received 01 Sep 2014, Accepted 25 Oct 2014, Published online: 03 Mar 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Morie A. Gertz. (2015) The role of bendamustine in the management of plasma cell myeloma. Leukemia & Lymphoma 56:5, pages 1195-1196.
Read now

Articles from other publishers (2)

İbrahim Halil Açar & Birol Güvenç. (2023) Efficacy of Bendamustine, Pomalidomide, and Dexamethasone (BPD) Regimen in Relapsed/Refractory Extramedullary Myeloma: A Retrospective Single-Centre Study, Real-Life Experience. Hematology Reports 15:3, pages 465-473.
Crossref
Seok Jin KimSoo-Mee BangYoon Seok ChoiDeog-Yeon JoJin Seok KimHyewon LeeHyeon Seok EomDok Hyun YoonCheolwon SuhJe-Jung LeeJunshik HongJae Hoon LeeYoungil KohKihyun KimSung-Soo YoonChang-Ki Min. (2016) Bendamustine in heavily pre-treated multiple myeloma patients: Results of a retrospective analysis from the Korean Multiple Myeloma Working Party. Blood Research 51:3, pages 193.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.